Outcome

This study on rats found that Hyperbaric Oxygen Therapy (HBOT) at 1.6 atmospheres absolute (ATA) especially when provided early after Traumatic Brain Injury (TBI) significantly reduced harmful extracellular histones decreased NF-κB signaling lowered neuronal cell death and improved recovery of neural function better than HBOT at 2.2 ATA or no treatment.

Introduction

This study aims to delve into the therapeutic benefits of hyperbaric oxygen therapy (HBOT) for treating traumatic brain injuries (TBI) specifically comparing two different pressures—1.6 atmospheres absolute (ATA) and 2.2 ATA. Research has previously confirmed the positive effects of HBOT for brain injuries but this study explores its impact on the expression of extracellular histones H1 H2A H4 and the inflammatory molecule NF-κB in rats. The study used 120 rats divided into four groups including Sham-operated TBI without HBOT TBI with 1.6 ATA HBOT and TBI with 2.2 ATA HBOT. Over various time points the researchers analyzed brain tissue to observe the expression of histones and NF-κB and noted the presence of neuronal cell death. The findings highlighted that 1.6 ATA HBOT especially when applied within six hours post-injury significantly reduced these toxic molecules’ levels decreased neuronal apoptosis and improved neural recovery better than 2.2 ATA HBOT or no treatment. These results indicate that early intervention with lower pressure HBOT could be more effective in mitigating secondary brain injuries and enhancing recovery though the study does not specify the number of treatments potential conflicts of interest or funding sources.

Results

The study investigated the effects of hyperbaric oxygen therapy (HBOT) at different pressures—1.6 atmospheres absolute (ATA) and 2.2 ATA—on traumatic brain injury (TBI) in rats. Key findings demonstrated that 1.6 ATA HBOT was notably more effective than 2.2 ATA HBOT in several critical measures.

Firstly 1.6 ATA HBOT significantly lowered modified Neurological Severity Scores (mNSS) which indicates improved neural function recovery at 48 hours post-TBI when compared to untreated TBI rats. This pressure also markedly reduced the mRNA and protein levels of extracellular histones (H1 H2A H4) and NF-κB especially within the first 6 hours following injury. The observed reductions in these indicators were more substantial with 1.6 ATA than with 2.2 ATA. At 12 and 48 hours post-TBI 1.6 ATA HBOT further decreased NF-κB positive staining rates in brain tissue near the lesion.

In terms of cellular effects 1.6 ATA HBOT reduced neuron apoptosis induced by histones at 24 and 48 hours post-TBI compared to untreated TBI rats. Thus the study suggests that HBOT at 1.6 ATA particularly when administered early can significantly inhibit the harmful effects of extracellular histones around the lesion and reduce nerve cell death thereby helping to alleviate secondary brain injury.

Overall these results indicate that 1.6 ATA HBOT is more beneficial than 2.2 ATA HBOT for improving outcomes after TBI in rats. However the study did not specify the number of HBOT sessions administered any potential conflicts of interest or the sources of funding.

Conclusion

In conclusion this study highlights the promising effects of hyperbaric oxygen therapy (HBOT) at 1.6 atmospheres absolute (ATA) for treating traumatic brain injuries (TBI) in rats. The findings reveal that early administration of 1.6 ATA HBOT significantly reduces the levels of harmful extracellular histones (H1 H2A H4) and the inflammatory marker NF-κB. These reductions are notably more pronounced than those observed with 2.2 ATA HBOT especially within the first six hours post-injury. Moreover 1.6 ATA HBOT demonstrates an ability to decrease neuronal apoptosis and enhance neural function recovery as indicated by lower mNSS scores.

These outcomes suggest that 1.6 ATA HBOT may attenuate the cytotoxic and pro-inflammatory effects of extracellular histones following TBI thereby contributing to better neurological outcomes. While the exact number of HBOT sessions potential conflicts of interest and funding sources were not disclosed the study provides valuable insights into the effectiveness of lower pressure HBOT in the early stages of TBI. This research underscores the potential of 1.6 ATA HBOT to improve brain health and aid in the recovery process after traumatic brain injuries through its impact on extracellular histones and NF-κB signaling pathways. Further studies are warranted to determine optimal treatment protocols and to explore these findings in human subjects.